DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Saregama India Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·8 Oct 2026, 11:18 am

Saregama India

Saregama India Limited has filed a certificate with stock exchanges under the SEBI (Depositories and Participants) Regulations, 2018. This regulatory filing is a standard corporate disclosure that confirms the company's compliance with the rules governing shareholding patterns and depository records.

For investors, this update is primarily a procedural notification. It does not signal any major business development or financial result. The disclosure is meant to ensure transparency regarding the company's shareholding structure and adherence to market regulations.

Investors should monitor the filing for any specific details regarding changes in shareholding patterns. However, based on the current information, the stock is not expected to see any immediate volatility due to this specific regulatory update.